Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Updates in Surgery
Published in: Updates in Surgery 3/2014

01-09-2014 | Original Article

Impact of perioperative symbiotic therapy on infectious morbidity after Hpb Surgery in jaundiced patients: a randomized controlled trial

Authors: N. Russolillo, A. Ferrero, L. Vigano’, S. Langella, A. Briozzo, M. Ferlini, M. Migliardi, L. Capussotti

Published in: Updates in Surgery | Issue 3/2014

Login to get access

Abstract

This study aimed at evaluating whether the administration of symbiotic therapy in jaundiced patients could reduce their postoperative infectious complications. The study was conducted between November 2008 and February 2011. Jaundiced patients scheduled for elective extrahepatic bile duct resection without liver cirrhosis, intestinal malabsorption or intolerance to symbiotic therapy were randomly assigned to receive [Group A] or not [Group B] symbiotics perioperatively. The primary endpoint was the infectious morbidity rate. Forty patients were included in the analysis (20 in each group). The patients in Group B presented a higher overall morbidity (70 vs 50 %) and infectious morbidity rate (50 vs 25 %), but the differences were not significant. Eleven patients in Group A (Group ndA) and 13 in Group B (Group ndB) did not receive preoperative biliary drainage. The results of the two groups were comparable. Infectious complications were higher in Group B [5 (34 %) vs 0, p = 0.030], while the prevalence of natural killer (NK) cells was higher in Group ndA the day before surgery (17 % ± 5.1 vs 10 % ± 5.3, p < 0.01) and on post-operative day (POD) 7 (13.1 % ± 4.1 vs 7.7 % ± 3.4, p < 0.01). The rates of lymph node colonization were similar. The symbiotic therapy failed to reduce the rate of infectious morbidity in jaundiced patients. Further studies investigating the place of symbiotic in no-drainage patients are required.
Literature
1.
Lai EC, Chu KM, Lo CY, Mok FP, Fan ST, Lo CM et al (1992) Surgery for malignant obstructive jaundice: analysis of mortality. Surgery 112:891–896PubMed
2.
Su CH, P’eng FK, Lui WY (1992) Factors affecting morbidity and mortality in biliary tract surgery. World J Surg 16:536–540CrossRefPubMed
3.
Greig JD, Krukowski ZH, Matheson NA (1998) Surgical morbidity and mortality in one hundred and twenty-nine patients with obstructive jaundice. Br J Surg 75:216–219CrossRef
4.
Pain JA, Cahill CJ, Bailey ME (1985) Perioperative complications in obstructive jaundice: therapeutic considerations. Br J Surg 72:942–945CrossRefPubMed
5.
Sewnath ME, Karsten TM, Prins MH, Rauws EJ, Obertop H, Gouma DJ (2002) A meta-analysis on the efficacy of preoperative biliary drainage for tumors causing obstructive jaundice. Ann Surg 236:17–27PubMedCentralCrossRefPubMed
6.
Assimakopoulos SF, Scopa CD, Zervoudakis G, Mylonas PG, Georgiou C, Nikolopoulou V (2005) Bombesin and neurotensin reduce endotoxemia, intestinal oxidative stress, and apoptosis in experimental obstructive jaundice. Ann Surg 241:159–167PubMedCentralPubMed
7.
Jin LZ, Ho YW, Abdullah N, Jalaludin S (2000) Digestive and bacterial enzyme activities in broilers fed diets supplemented with Lactobacillus cultures. Poult Sci 79:886–891CrossRefPubMed
8.
Erickson KE, Hubbard NE (2000) Probiotic immunomodulation in health and disease. Am Soc Nutr Sc 2000(130):403S–409S
9.
Assimakopoulos SF, Vagianos CE, Patsoukis N, Georgiou C, Nikolopoulou V, Scopa CD (2004) Evidence for intestinal oxidative stress in obstructive jaundice-induced gut barrier dysfunction in rats. Acta Physiol Scand 180:177–185CrossRefPubMed
10.
Ogata Y, Nishi M, Nakayama H, Kuwahara T, Ohnishi Y, Tashiro S (2003) Role of bile in intestinal barrier function and its inhibitory effect on bacterial translocation in obstructive jaundice in rats. J Surg Res 115:18–23CrossRefPubMed
11.
Greig JD, Krukowski ZH, Matheson NA (1988) Surgical morbidity and mortality in one hundred and twenty-nine patients with obstructive jaundice. Br J Surg 75:216–219CrossRefPubMed
12.
Clements WD, Parks R, Erwin P, Halliday MI, Barr J, Rowlands BJ (1996) Role of the gut in the pathophysiology of extrahepatic biliary obstruction. Gut 39:587–593PubMedCentralCrossRefPubMed
13.
Yang R, Harada T, Li J, Uchiyama T, Han Y, Englert JA, Fink MP (2005) Bile modulates intestinal epithelial barrier function via an extracellular signal related kinase 1/2 dependent mechanism. Intensive Care Med 31:709–717CrossRefPubMed
14.
Assimakopoulos SF, Vagianos CE (2007) Pathophysiology of increased intestinal permeability in obstructive jaundice. World J Gastroenterol 13:6458–6464CrossRefPubMed
15.
Gratz SW, Mykkanen H, El-Nezami HS (2010) Probiotics and gut health: a special focus on liver diseases. World J Gastroenterol 6:403–410CrossRef
16.
Albers R, Antoine JM, Bourdet-Sicard R, Calder PC, Gleeson M, Lesourd B (2005) Markers to measure immunomodulation in human nutrition intervention studies. Br J Nutr 94:452–455CrossRefPubMed
17.
Madsen K, Cornish A, Soper P, McKaigney C, Jijon H, Yachimec C, Doyle J, Jewell L, De Simone C (2001) Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology 121:580–591CrossRefPubMed
18.
Li Z, Yang S, Lin H, Huang J, Watkins PA, Abet Moser (2003) Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease. Hepatology 37:343–350CrossRefPubMed
19.
Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–513PubMedCentralCrossRefPubMed
20.
American College of Chest Physicians/Society of Critical Care (1992) Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20:864–874CrossRef
21.
Shigeta H, Nagino M, Kamiya J, Uesaka K, Sano T, Yamamoto H (2002) Bacteremia after hepatectomy: an analysis of a single-center, 10-year experience with 407 patients. Langenbecks Arch Surg 387:117–124CrossRefPubMed
22.
Rayes N, Seehofer D, Neuhaus P (2009) Prebiotics, probiotics, synbiotics in surgery-are they only trendy, truly effective or even dangerous? Langenbecks Arch Surg 394:547–555CrossRefPubMed
23.
Kanazawa H, Nagino M, Kamiya S, Komatsu S, Mayumi T, Takagi K (2005) Synbiotics reduce postoperative infectious complications: a randomized controlled trial in biliary cancer patients undergoing hepatectomy. Langenbecks Arch Surg 390:104–113CrossRefPubMed
24.
Sugawara G, Nagino M, Nishio H, Ebata T, Takagi K, Asahara T, Nomoto K, Nimura Y (2006) Perioperative synbiotic treatment to prevent postoperative infectious complications in biliary cancer surgery: a randomized control trial. Ann Surg 5:706–714CrossRef
25.
Kamiya S, Nagino M, Kanazawa H, Komatsu S, Mayumi T, Takagi K, Asahara T, Nomoto K, Tanaka R, Nimura Y (2004) The value of bile replacement during external biliary drainage: an analysis of intestinal permeability, integrity, and microflora. Ann Surg 239:510–517PubMedCentralCrossRefPubMed
26.
Kinross J, Warren O, Silk D, Darzi A (2007) Perioperative synbiotic treatment to prevent postoperative infectious complications in biliary cancer surgery: a randomized control trial. Ann Surg 245:1000PubMedCentralCrossRefPubMed
27.
Gionotti L, Alexander JW, Nelson JL (1994) Role of early enteral feeding and acute starvation on post burn bacterial translocation and host defense: prospective, randomized trials. Crit Care Med 22:265–272CrossRef
28.
Kudsk KA, Croce MA, Fabian TC, Minard G, Tolley EA, Poret HA (1992) Enteral versus parenteral feeding: effects on septic morbidity after blunt and penetrating abdominal trauma. Ann Surg 215:503–513PubMedCentralCrossRefPubMed
29.
Petrov MS, Loveday BP, Pylypchuk RD, McIlroy K, Phillips AR, Windsor JA (2009) Systematic review and meta-analysis of enteral nutrition formulations in acute pancreatitis. Br J Surg 96:1243–1252CrossRefPubMed
30.
Petrov MS, van Santvoort HC, Besselink MG, van der Heijden GJ, Windsor JA, Gooszen HG (2008) Enteral nutrition and the risk of mortality and infectious complications in patients with severe acute pancreatitis: a meta-analysis of randomized trials. Arch Surg 143:1111–1117CrossRefPubMed
31.
Ishizawa T, Hasegawa K, Sano K, Imamura H, Kokudo N, Makuuchi M (2007) Selective versus total biliary drainage for obstructive jaundice caused by a hepatobiliary malignancy. Am J Surg 193:149–154CrossRefPubMed
32.
Povoski SP, Karpeh MS Jr, Conlon KC, Blumgart LH, Brennan MF (1999) Association of preoperative biliary stenting with increased postoperative infectious complications in proximal cholangiocarcinoma. Arch Surg 134:261–266CrossRef
33.
Ferrero A, Lo Tesoriere R, Viganò L, Caggiano L, Sgotto E, Capussotti L (2009) Preoperative biliary drainage increases infectious complications after hepatectomy for proximal bile duct tumor obstruction. World J Surg 33:318–325CrossRefPubMed
34.
35.
MacFie J, Reddy BS, Gatt M, Jain PK, Sowdi R, Mitchell CJ (2006) Bacterial translocation studied in 927 patients over 13 years. Br J Surg 93:87–93CrossRefPubMed
36.
MacFie J, O’Boyle CJ, Mitchell CJ, Buckley PM, Johnstone D, Sudworth P (1999) Gut origin of sepsis: a prospective study investigating associations between bacterial translocation, gastric microflora, and septic morbidity. Gut 45:223–228PubMedCentralCrossRefPubMed
37.
Albers R, Antoine JM, Bourdet-Sicard R, Calder PC, Gleeson M, Lesourd B, Samartín S, Sanderson IR, Van Loo J, Vas Dias FW, Watzl B (2005) Markers to measure immunomodulation in human nutrition intervention studies. Br J Nutr 94:452–481CrossRefPubMed
38.
39.
Westrate JA, Van Poppel G, Verschuren PM (2002) Functional foods, trends and future. Br J Nutr 88:S233–S235CrossRef
Metadata
Title
Impact of perioperative symbiotic therapy on infectious morbidity after Hpb Surgery in jaundiced patients: a randomized controlled trial
Authors
N. Russolillo
A. Ferrero
L. Vigano’
S. Langella
A. Briozzo
M. Ferlini
M. Migliardi
L. Capussotti
Publication date
01-09-2014
Publisher
Springer Milan
Published in
Updates in Surgery / Issue 3/2014
Print ISSN: 2038-131X
Electronic ISSN: 2038-3312
DOI
https://doi.org/10.1007/s13304-014-0259-y

Other articles of this Issue 3/2014

Updates in Surgery 3/2014 Go to the issue

Letter to the Editor

Locally advanced pancreatic cancer: open questions on terminology, diagnosis and management

Letter to the Editor

Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): an analysis of tumor activity

Erratum

Erratum to: Laparoscopic vs. open surgery for treating benign liver lesions: assessing quality of life in the first year after surgery

Review Article

High-resolution manometry for the evaluation of gastric motility

Editorial and Commentary

Clinical-judicial syndrome: how a doctor becomes a patient through general indifference

Obituary

The memory of a friend: Lorenzo Capussotti (1947–2014)